[BENGALURU] Europe’s Stoxx 600 closed at a record high on Wednesday (Oct 1), with healthcare stocks leading the way after a US-Pfizer deal reduced uncertainty in the sector, while investors digested the beginning of a US government shutdown.
The pan-European Stoxx 600 surged 1.2 per cent to log its biggest one-day percentage gain since Jul 23. Most regional bourses were also trading higher, with London’s FTSE 100 at a record high.
Healthcare stocks jumped 5.4 per cent, marking their biggest one-day performance since November 2008. On Tuesday, Pfizer agreed to lower prescription drug prices in the US Medicaid programme in exchange for tariff relief.
“The sector generally has struggled over the last year or so and what we are hopefully beginning to see is some measure of clarity about what the rules of the game may look like,” said Richard Flax, chief investment officer at Moneyfarm.
Other pharma stocks such as Ambu rose 9.3 per cent, Sartorius 9.5 per cent, Merck 10 per cent, Roche 8.6 per cent and AstraZeneca 11.2 per cent.
Novartis gained 3.9 per cent after the US Food and Drug Administration approved its oral treatment for a type of chronic inflammatory skin disease.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
All sectors were trading in the positive territory, but travel and leisure stocks bucked the trend with a 0.4 per cent dip.
Meanwhile, the US government shut down much of its operations on Wednesday, which could likely halt the release of the September employment report due on Friday.
The absence of data is expected to increase volatility in markets and potentially impair the Federal Reserve’s ability to gauge the economy’s health in the near-term.
SEE ALSO
A private payrolls report came in below expectations earlier in the day, slightly raising bets on an October interest rate cut in the US.
“The Fed is still very likely to cut again in October, but given the importance of the labour market in its thinking at the moment…, this lack of data clarity certainly won’t make its job any easier,” said Luke Bartholomew, deputy chief economist at Wealth & Investments Group Aberdeen.
In Europe, data showed eurozone manufacturing activity slipped back into contraction in September, while inflation accelerated on higher services prices and a smaller decline in energy costs.
Manufacturing activity in the UK shrank at the fastest pace in five months. A decline was also reported from France and Germany.
UK blue-chips remained higher on the healthcare boost, while the midcap index reversed early declines to close 0.2 per cent higher.
London’s Tate & Lyle dropped 13 per cent to the bottom of the Stoxx 600 after the food ingredients maker warned that its annual profit and revenue would fall. REUTERS
